The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...

For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained endogenous factor IX expression and low annualized bleeding rates over five ...

For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained endogenous factor IX expression and low annualized bleeding rates over five ...

Superwarfarins represent a class of long‐acting anticoagulant rodenticides that exert their effect through profound inhibition of vitamin K recycling, primarily by targeting vitamin K epoxide ...

Coagulation disorders in canine medicine encompass a range of conditions in which the delicate balance between procoagulant and anticoagulant processes is disturbed. Disorders such as ...

Researchers at McMaster University have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite ...

People living with cancer face a significantly higher risk of dying from cardiovascular diseases, according to new research ...

A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with full-dose ...

Patients with cancer are more likely to die from cardiovascular diseases, according to a study.The study, published in the ...

A patient died after receiving Pfizer Inc.’s drug for hemophilia, marking another setback for the company in the treatment of ...